Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 8,171 | 6,687 | 7,951 | 7,367 | 6,733 |
| Cost of Goods | 3,857 | 3,435 | 4,551 | 3,997 | 3,256 |
| Gross Profit | 4,314 | 3,252 | 3,400 | 3,370 | 3,477 |
| Operating Expenses | 12,389 | 11,584 | 12,487 | 12,905 | 11,533 |
| Operating Income | -7,218 | -7,897 | -8,536 | -8,538 | -7,800 |
| Other Income | -198 | -396 | 639 | 49 | 953 |
| Pre-tax Income | -7,416 | -8,293 | -7,897 | -8,489 | -6,847 |
| Income Tax | 7 | 10 | 36 | 14 | 10 |
| Net Income Continuous | -7,423 | -8,303 | -7,933 | -8,503 | -6,857 |
| Net Income | $-7,423 | $-8,303 | $-7,933 | $-8,503 | $-6,857 |
| EPS Basic Total Ops | -0.64 | -0.76 | -0.12 | -1.59 | -1.99 |
| EPS Basic Continuous Ops | -0.64 | -0.76 | -0.11 | -1.59 | -1.99 |
| EPS Diluted Total Ops | -0.64 | -0.76 | -0.12 | -1.59 | -1.99 |
| EPS Diluted Continuous Ops | -0.64 | -0.76 | -0.11 | -1.59 | -1.99 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.76 | -0.03 | -1.59 | -1.99 |
| EBITDA(a) | $-4,980 | $-5,730 | $-6,397 | $-6,347 | $-5,618 |